Award
National Cancer Institute 5R00CA267560-05
Radiation dosimetry for alpha-particle radiopharmaceutical therapy and application to pediatric neuroblastoma
Recipient
Massachusetts General Hospital, Boston, MA, United States
Award Amount
$248,997.00
Ceiling
$248,997.00
Awarded
September 03, 2025
Identifier
5R00CA267560-05
Award for research on alpha-particle radiopharmaceutical therapy for pediatric neuroblastoma, including dosimetry and biological modeling, funded by the National Cancer Institute.
Description
The project involves research on alpha-particle radiopharmaceutical therapy targeting pediatric neuroblastoma. The project includes microdosimetry calculations, DNA damage modeling, biodistribution studies, and collaboration with experts in radiobiology and Monte Carlo simulations. The award is funded by the National Cancer Institute, NIH.